Join
Live feed
·
PRReleasevia Quantisnow
Natera Inc. logo

Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

ByQuantisnow·Wall Street's wire, on your screen.
NTRA· Natera Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTRA (Natera Inc.) and more on Quantisnow.